title: [Chemoembolization and posterior liver transplantation as therapeutic strategy for hepatocarcinoma].
abstract: Orthotopic Liver Transplantation (OLT) is the only surgical approach to non-resectable hepatocellular carcinoma (HCC) but, so far its results has been poor. During 41 months 112 patients underwent 123 OLT, nine of them had HCC over cirrhosis with a mean age 60 years. The etiology of cirrhosis was: alcohol in 1 and viral hepatitis in 8. Child's grade: A in 4, B in 5. HCC was: 5 cm or less in 5 and more in 4. According pTNM staging: I in one, II in 5, II in 2 and IVb in 1. Differentiation degree: low in 1, moderate in 4, and well in 3 (one case with complete necrosis after embolization). Eight patients were previously embolized with lipiodol, adriamycin and gelfoam, obtaining central necrosis without viable features in periphery. There were no postoperative deaths, and all the patients were discharged from the hospital. During follow up, 3 recurrences were observed, one massive with death of the patient after 6 months, and the other was surgically removed (segmentectomy V, VI) after 4 months after OLT without recurrence at 18 months of resection. In the third case a focal lesions was detected in the U.S. and T.C. study, 4 months after OLT, but in wasn't possible to obtain a biopsy because its posterior location; no treatment was made, and she's alive today. In conclusion, OLT is a good surgical option for non resectable HCC complicating cirrhosis if the patient is adequately selected. Chemoembolization has a good local effect, obtaining tumoral necrosis, but it does not decrease the posterior growth of the tumor in other localizations.
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario Gregorio Marañón, Madrid.
authors.forename: M
authors.initials: M
authors.lastname: Salcedo
authors.forename: R
authors.initials: R
authors.lastname: Bañares
authors.forename: C
authors.initials: C
authors.lastname: Asanza
authors.forename: B
authors.initials: B
authors.lastname: Jaime
authors.forename: L
authors.initials: L
authors.lastname: Santos
authors.forename: J
authors.initials: J
authors.lastname: Ferreiroa
authors.forename: J
authors.initials: J
authors.lastname: Calleja
authors.forename: G
authors.initials: G
authors.lastname: Sabrido
authors.forename: E
authors.initials: E
authors.lastname: Alvarez
authors.forename: E
authors.initials: E
authors.lastname: Cos
mesh_terms: D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D016019:Survival Analysis
vernacular_title: Quimioembolización y posterior trasplante hepático como estrategia terapéutica del hepatocarcinoma.